Overview

Mirvaso® Gel and Dysport® for Erythema and Flushing of Rosacea

Status:
Terminated

Trial end date:
2017-09-20

Target enrollment:

Participant gender:

Summary

To evaluate the safety and efficacy of Mirvaso® Gel and Dysport® for erythema and flushing of Rosacea.

Phase:

N/A

Details

Lead Sponsor:

Skin Laser & Surgery Specialists

Collaborators:

Galderma
Galderma R&D

Treatments:

abobotulinumtoxinA
Acetylcholine Release Inhibitors
Adrenergic Agonists
Adrenergic alpha-Agonists
Botulinum Toxins, Type A
Brimonidine Tartrate
Neuromuscular Blocking Agents
onabotulinumtoxinA